Heidi Leblanc

Heidi LeBlanc is an accomplished professional in the field of immuno-oncology and translational medicine, currently serving as Associate Director at Omeros Corporation, focusing on novel therapeutics for cancer. With prior leadership roles at Alpine Immune Sciences, Bolt Biotherapeutics, and Bristol-Myers Squibb, Heidi has extensive experience in developing biomarkers for early-stage research and clinical applications, managing cross-functional collaborations, and overseeing translational strategies. A holder of a PhD in Microbiology from The University of British Columbia and a BSc in Biochemistry from the University of Waterloo, Heidi has made significant contributions to the advancement of antibody-drug conjugates and immuno-modulatory therapies, resulting in multiple patents and publications throughout a diverse career spanning over two decades in prestigious organizations.